Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,894 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | AKTS | Aktis Oncology, Inc. | Wedbush | Initiated | — | Outperform | — | — | $4.92 | -78.77% | 1.06B |
| Aug 19, 2026 | AKTS | Aktis Oncology, Inc. | BMO Capital | Initiated | — | Outperform | — | — | $4.92 | -78.77% | 1.06B |
| Aug 19, 2026 | ALNY | Alnylam Pharmaceuticals, Inc. | BMO Capital | Initiated | Outperform | Outperform | Buy | 20 | $495.36 | +98.15% | 44.15B |
| Aug 19, 2026 | ALZN | Alzamend Neuro, Inc. | Ascendiant Capital | Main | Buy | Buy | Buy | 8 | $42.84 | +2348.00% | 6.31M |
| Aug 19, 2026 | AMGN | Amgen Inc. | Argus Research | Main | Buy | Buy | Hold | 21 | $368.50 | -3.41% | 209.24B |
| Aug 19, 2026 | AMH | American Homes 4 Rent | JP Morgan | Main | Neutral | Neutral | — | — | $36.17 | +14.35% | 11.11B |
| Aug 19, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Guggenheim | Main | Buy | Buy | — | — | $20.00 | -40.55% | 1.26B |
| Aug 19, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Baird | Main | Outperform | Outperform | — | — | $20.00 | -40.55% | 1.26B |
| Aug 19, 2026 | AMLX | Amylyx Pharmaceuticals, Inc. | Mizuho | Main | Outperform | Outperform | — | — | $20.00 | -40.55% | 1.26B |
| Aug 19, 2026 | AON | Aon plc | Morgan Stanley | Main | Overweight | Overweight | Buy | 15 | $411.00 | +31.93% | 72.1B |
| Aug 19, 2026 | APA | APA Corporation | Argus Research | Upgrade | Hold | Buy | Hold | 35 | $25.83 | -42.64% | 10.77B |
| Aug 19, 2026 | APP | AppLovin Corporation | Wells Fargo | Main | Equal-Weight | Equal-Weight | Buy | 20 | $730.55 | +118.57% | 147.09B |
| Aug 19, 2026 | ARDX | Ardelyx, Inc. | Wedbush | Reiterated | Outperform | Outperform | — | — | $12.00 | +240.91% | 1.59B |
| Aug 19, 2026 | ARMK | Aramark | RBC Capital | Main | Outperform | Outperform | — | — | $45.00 | -23.12% | 11B |
| Aug 19, 2026 | AS | Amer Sports, Inc. | Barclays | Main | Overweight | Overweight | Buy | 29 | $44.23 | +60.54% | 21.06B |
| Aug 19, 2026 | AS | Amer Sports, Inc. | Truist Securities | Main | Buy | Buy | Buy | 29 | $44.23 | +60.54% | 21.06B |
| Aug 19, 2026 | ASND | Ascendis Pharma A/S | BMO Capital | Initiated | — | Outperform | — | — | $246.67 | -6.89% | 14.33B |
| Aug 19, 2026 | AVHHL | AVITA Medical, Inc. | TD Cowen | Main | Buy | Buy | — | — | — | — | 97.76M |
| Aug 19, 2026 | AVHHL | AVITA Medical, Inc. | BTIG | Main | Buy | Buy | — | — | — | — | 97.76M |
| Aug 19, 2026 | BALY | Bally's Corporation | Barclays | Main | Underweight | Underweight | — | — | $19.00 | +93.09% | 660.56M |
| Aug 19, 2026 | BALY | Bally's Corporation | Truist Securities | Main | Hold | Hold | — | — | $19.00 | +93.09% | 660.56M |
| Aug 19, 2026 | BAND | Bandwidth Inc. Class A Common Stock | Piper Sandler | Main | Neutral | Neutral | — | — | $16.00 | -67.33% | 460.01M |
| Aug 19, 2026 | BCAX | Bicara Therapeutics Inc. Common Stock | BMO Capital | Initiated | — | Outperform | — | — | $40.00 | +72.41% | 1.03B |
| Aug 19, 2026 | BDC | Belden Inc. | DA Davidson | Main | Buy | Buy | — | — | $134.00 | +18.16% | 4.98B |
| Aug 19, 2026 | BIDU | Baidu, Inc. | Morgan Stanley | Downgrade | Equal-Weight | Underweight | Buy | 11 | $155.57 | +69.28% | 43.53B |
| Aug 19, 2026 | BIDU | Baidu, Inc. | Barclays | Main | Equal-Weight | Equal-Weight | Buy | 11 | $155.57 | +69.28% | 43.53B |
| Aug 19, 2026 | BIDU | Baidu, Inc. | Benchmark | Main | Buy | Buy | Buy | 11 | $155.57 | +69.28% | 43.53B |
| Aug 19, 2026 | BKU | BankUnited, Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | — | — | $48.25 | +8.50% | 3.48B |
| Aug 19, 2026 | BMRN | BioMarin Pharmaceutical Inc. | BMO Capital | Initiated | Outperform | Outperform | — | — | $80.58 | +21.34% | 10.18B |
| Aug 19, 2026 | BOW | Bowhead Specialty Holdings Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $33.75 | +0.09% | 891.74M |
| Aug 19, 2026 | BRO | Brown & Brown, Inc. | Morgan Stanley | Main | Underweight | Underweight | — | — | $120.00 | +75.62% | 27.16B |
| Aug 19, 2026 | CAH | Cardinal Health, Inc. | RBC Capital | Initiated | — | Outperform | Buy | 13 | $211.22 | -10.08% | 47.1B |
| Aug 19, 2026 | CATX | Perspective Therapeutics, Inc. | BMO Capital | Initiated | — | Outperform | — | — | $10.50 | +259.59% | 200.3M |
| Aug 19, 2026 | CB | Chubb Limited | Morgan Stanley | Main | Equal-Weight | Equal-Weight | Hold | 21 | $303.50 | -11.22% | 122.4B |
| Aug 19, 2026 | CCOI | Cogent Communications Holdings, Inc. | JP Morgan | Downgrade | Neutral | Underweight | — | — | $36.75 | +294.31% | 1.19B |
| Aug 19, 2026 | CFG | Citizens Financial Group, Inc. | Cantor Fitzgerald | Main | Overweight | Overweight | Buy | 27 | $61.13 | -13.34% | 25.06B |
| Aug 19, 2026 | CFR | Cullen/Frost Bankers, Inc. | Cantor Fitzgerald | Main | Neutral | Neutral | Hold | 20 | $141.80 | -13.21% | 8.36B |
| Aug 19, 2026 | CIEN | Ciena Corporation | Northland Capital Markets | Upgrade | Market Perform | Outperform | — | — | $197.50 | -38.21% | 34.24B |
| Aug 19, 2026 | CLYM | Climb Bio, Inc. | Wedbush | Reiterated | Outperform | Outperform | Buy | 12 | $9.38 | -35.55% | 157.17M |
| Aug 19, 2026 | CME | CME Group Inc. | Deutsche Bank | Downgrade | Buy | Hold | Hold | 14 | $296.20 | +5.61% | 98.23B |
| Aug 19, 2026 | CNH | CNH Industrial N.V. | DA Davidson | Main | Neutral | Neutral | — | — | $11.33 | -17.60% | 12.41B |
| Aug 19, 2026 | CNR | Core Natural Resources, Inc. | UBS | Downgrade | Buy | Neutral | — | — | $115.25 | +19.68% | 4.48B |
| Aug 19, 2026 | COLL | Collegium Pharmaceutical, Inc. | Barclays | Main | Overweight | Overweight | — | — | $58.00 | +154.27% | 1.53B |
| Aug 19, 2026 | COP | ConocoPhillips | Morgan Stanley | Main | Overweight | Overweight | Buy | 20 | $115.18 | -15.72% | 120.47B |
| Aug 19, 2026 | COP | ConocoPhillips | Argus Research | Main | Buy | Buy | Buy | 20 | $115.18 | -15.72% | 120.47B |
| Aug 19, 2026 | COR | Cencora, Inc. | RBC Capital | Initiated | — | Sector Perform | Buy | 14 | $373.17 | +14.39% | 66.71B |
| Aug 19, 2026 | CPB | Campbell Soup Company | TD Cowen | Main | Hold | Hold | — | — | $30.88 | +45.32% | 8.48B |
| Aug 19, 2026 | CRBG | Corebridge Financial, Inc. | Wells Fargo | Main | Overweight | Overweight | — | — | $37.25 | +7.04% | 17.55B |
| Aug 19, 2026 | CRK | Comstock Resources, Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $15.50 | +8.39% | 6.3B |
| Aug 19, 2026 | CRWD | CrowdStrike Holdings, Inc. Class A Common Stock | Mizuho | Main | Outperform | Outperform | Buy | 46 | $545.93 | +131.94% | 128.96B |
